(IDLV) |
| 0 (0%) 10-29 10:53 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 41.60 |
| Resistance 1: | 35.62 |
| Pivot price: | 34.89 |
| Support 1: | 34.46 |
| Support 2: | 33.75 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Thu, 22 Oct 2026
How Invesco S&p International Developed Low Volatility Etf (IDLV) Affects Rotational Strategy Timing - Stock Traders Daily
Mon, 12 Oct 2026
Understanding Momentum Shifts in (IDLV) - Stock Traders Daily
Wed, 18 Feb 2026
Viral genome editing methods and applications in the CRISPR era - ASM Journals
Mon, 10 Feb 2025
Customizable virus-like particles deliver CRISPR–Cas9 ribonucleoprotein for effective ocular neovascular and Huntington’s disease gene therapy - Nature
Mon, 10 Jun 2024
Efficient site-specific integration of large genes in mammalian cells via continuously evolved recombinases and prime editing - Nature
Wed, 22 Feb 2023
In search of an ideal template for therapeutic genome editing: A review of current developments for structure optimization - Frontiers
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
